A comprehensive view of Approval Recommendations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BIOGEN INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published: April 24, 2024 by SEC Edgar Filings
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published: April 24, 2024 by CE Noticias Financieras (Latin America)
US Patent Issued to GLAXOSMITHKLINE on April 23 for "Platelet count-agnostic methods of treating myelofibrosis" (Michigan Inventors)
Published: April 24, 2024 by U.S. Fed News
European Commission approves Pfizer’s EMBLAVEO for patients with multidrug-resistant infections and limited treatment options; antimicrobial resistance is recognized as one of the biggest threats to global health
Published: April 22, 2024 by Pfizer Inc.
'Solid Forms And Combination Compositions Comprising A Beta-Lactamase Inhibitor And Uses Thereof' in Patent Application Approval Process (USPTO 20240101580)
Published: April 15, 2024 by NewsRx Drug Daily

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count